Acknowledgements
We are indebted to our volunteers, and thankful to the team at the
Centre for Human Drug Research and the pharmacy of the Leiden University
Medical Center. Thanks to Karen Broekhuizen, medical writer at the
Centre for Human Drug Research, who edited the manuscript for clarity.
Conflict of interest
Wim Jiskoot is a scientific advisor at Coriolis Pharma, Martinsried.
Theo Rispens received fees for lectures from Pfizer, AbbVie, and
Regeneron, and a research grant from Genmab. Koen van der Maaden is
scientific advisor of MyLife Technologies B.V. and co-founder of uPRAX
microsolutions B.V. The other authors have declared no conflict of
interest exists.